FDA May Convene Covid-19 Vaccine Panel on October 22

Aug. 20, 2020, 2:36 PM

The Food and Drug Administration is tentatively planning an advisory panel to meet Oct. 22 to discuss a Covid-19 vaccine, the agency’s deputy commissioner for medical and scientific affairs Anand Shah said. Shah did not specify which vaccines, or how many, may be scrutinized at the meeting.

  • The committee may also be bolstered by scientific experts on the novel coronavirus, Shah said on a call with reporters
    • Investors have been trying to handicap when a vaccine may receive a regulatory nod, with some arguing that an authorization could come prior to the Nov. 4 U.S. general election
    • Companies leading the ...

To read the full article log in.

Learn more about a Bloomberg Law subscription.